Cargando…

NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations

The 5-fluorouracil (5-FU) treatment induces DNA damage and stalling of DNA replication forks. These stalled replication forks then collapse to form one sided double-strand breaks, leading to apoptosis. However, colorectal cancer (CRC) stem cells rapidly repair the stalled/collapsed replication forks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayan, Satya, Jaiswal, Aruna S., Sharma, Ritika, Nawab, Akbar, Duckworth, Lizette Vila, Law, Brian K., Zajac-Kaye, Maria, George, Thomas J., Sharma, Jay, Sharma, Arun K., Hromas, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593639/ https://www.ncbi.nlm.nih.gov/pubmed/28915668 http://dx.doi.org/10.18632/oncotarget.19778

Ejemplares similares

NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells
por: Jaiswal, Aruna S., et al.
Publicado: (2015)

ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells
por: Narayan, Satya, et al.
Publicado: (2019)

Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
por: Yang, Jingbo, et al.
Publicado: (2022)

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2021)

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2022)

The DNA repair component Metnase regulates Chk1 stability
por: Williamson, Elizabeth A, et al.
Publicado: (2014)

NSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in mice
por: Zhang, Ruolin, et al.
Publicado: (2023)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously.
por: Jodrell, D. I., et al.
Publicado: (1998)

Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

5‐FU inhibits migration and invasion of CRC cells through PI3K/AKT pathway regulated by MARCH1
por: Wang, Nuan, et al.
Publicado: (2020)

Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment
por: Brockmueller, Aranka, et al.
Publicado: (2023)

Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival
por: Matta, Rita, et al.
Publicado: (2021)

Colorectal Cancer (CRC): Investigating the Expression of the Suppressor of Fused (SuFu) Gene and Its Relationship with Several Inflammatory Blood-Based Biomarkers
por: Rather, Tahseen Bilal, et al.
Publicado: (2023)

NSC800 microprocessor family handbook.
Publicado: (1981)

ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway
por: Yang, Hao, et al.
Publicado: (2023)

Letter to the Member of the NSC and others concerned on the fusion of the NSC with Emulsion Experiments Committee into the new Physics III Committee
por: Ericson, T
Publicado: (1966)

Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
por: Haritha, Nair Hariprasad, et al.
Publicado: (2021)

ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC
por: Stockwin, Luke H, et al.
Publicado: (2009)

A unique presentation of 5-fluorouracil (5-FU) induced cerebral encephalopathy
por: Naik, Shailendra S, et al.
Publicado: (2020)

Agenda for the meeting of the NSC on 11 January 1965
por: Ericson, T
Publicado: (1965)

Agenda for the NSC meeting on 12 February 1965
por: Ericson, T
Publicado: (1965)

Agenda for the NSC meeting on 12 March 1965
por: Ericson, T
Publicado: (1965)

Agenda for the NSC meeting on 15 November 1965
por: CERN. Geneva. Nuclear Structure Committee
Publicado: (1965)

Agenda for the NSC meeting on 13 June 1966
por: Ericson, T
Publicado: (1965)

Third Conference on nonlinear science and complexity (NSC)
por: Luo, Albert, et al.
Publicado: (2012)

Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
por: Boven, E., et al.
Publicado: (1990)

Regulation of Chk1
por: Tapia-Alveal, Claudia, et al.
Publicado: (2009)

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925
por: Yang, X, et al.
Publicado: (2014)

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
por: Šašinková, Markéta, et al.
Publicado: (2021)

WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells
por: Moles, R., et al.
Publicado: (2016)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

Regulation, targets and functions of CHK
por: Zhu, Shudong, et al.
Publicado: (2022)

CRC handbook of microbiology
Publicado: (1988)

Oxidative stress in NSC-741909-induced apoptosis of cancer cells
por: Wei, Xiaoli, et al.
Publicado: (2010)

Minutes of the 1st Meeting of the NSC on 12 September 1964
por: Soergel, V
Publicado: (1964)

Minutes of the 2nd meeting of the NSC, 16 October 1964
por: Soergel, V
Publicado: (1964)

Minutes of the 3rd meeting of the NSC, 11 January 1965
por: Ericson, T
Publicado: (1965)

Minutes of the 4th meeting of the NSC, 12 March 1965
por: CERN. Geneva. Nuclear Structure Committee
Publicado: (1965)

Minutes of the 6th meeting of the NSC, 31 January 1966
por: CERN. Geneva. Nuclear Structure Committee
Publicado: (1966)

Cannot write session to /tmp/vufind_sessions/sess_m7fq8afpnrdo1vbrqi068ctr14